SHetA2 treatment caused nuclear and mitochondrial accumulation of p53 and apoptosis in ovarian cancer cell lines, but not in primary cultures of human fallopian tube secretory epithelial cells. This evidence concerns the gene TP53 and ovarian carcinoma.